# X4 Pharmaceuticals, Inc: Form 8-K, filed Feb 6, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2025-02-06
- Accepted by EDGAR: Feb 6, 2025, 16:06 ET
- Period: 2025-02-06
- Accession: 0001628280-25-004254
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025004254/xfor-20250206.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828025004254/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828025004254/xfor-20250206.htm

Filed Feb 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-004254. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.